SecBot SecBot
SC 13G ·Filed Nov 9, 2026

STRO

SUTRO BIOPHARMA, INC.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7d 13h ago SEC0001104659-26-124373
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any subsequent amendments or a potential conversion to a 13D if the fund's intent changes. The stake is just above the 5% threshold, so further accumulation or reduction will trigger additional filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$10.61
T+0 close · Nov 9, 2026 · via day close
Latest settled
−12.16%
T+5 · $9.32
Vs SPY
−10.47%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $10.61entry
  2. T+1 · 7d ago −4.15%α −3.78% · $10.17
  3. T+5 · 20h ago −12.16%α −10.47% · $9.32
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Coastlands Capital LP disclosed a new 5.14% passive stake in Sutro Biopharma, holding 852,669 shares as of November 5, 2026. This is a new 13G filing, not an amendment, indicating a fresh position crossing the 5% threshold. The stake is modest in size and the fund certifies passive intent, making this a routine disclosure with limited immediate price impact.

Key Financial Metrics

Stake
5.14%
Investor
Coastlands Capital LP
Investor Type
hedge fund

Key Facts

  • Coastlands Capital LP filed a new Schedule 13G disclosing beneficial ownership of 852,669 shares of Sutro Biopharma common stock.
  • The stake represents 5.14% of shares outstanding, based on 16,581,171 shares outstanding as of August 7, 2026.
  • The filing certifies passive intent under Rule 13d-1(b) and (c), with no purpose of changing or influencing control.
  • The shares are held directly by Coastlands Capital Partners LP; the reporting persons include Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry.
  • This is a new position (initial 13G), not an amendment to a prior filing.

Financial Impact

852,669 shares valued at approximately $4.3M based on market cap of $152M and 16.58M shares outstanding.

ownership concentration

Risk Factors

  • Passive 13G status could change if the fund later engages with management or seeks board representation, requiring a 13D filing.
  • No indication of activist intent; the filing is routine and unlikely to drive near-term stock movement.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001104659-26-124373
Document: 0001104659-26-124373-index-headers.html0001104659-26-124373
Document: 0001104659-26-124373-index.html0001104659-26-124373
Document: 0001104659-26-124373.txt0001104659-26-124373

Track record

8 reports on STRO

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +50.74% at T+20 after the Mar 23, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago Press Release Bearish 5/10 Entry $9.82 to $9.32 Now $9.32 +5.09% ▲ +5.09% +3.18% vs SPY
  2. Nov 9, 20267d ago SC 13G Neutral 3/10 Viewing Entry $10.61 to $10.17 Now $9.32 −12.16% ▼ −4.15% −3.78% vs SPY
  3. Aug 12, 202613w ago 8-K Bullish 7/10 No price data
  4. Aug 12, 202613w ago Press Release Mixed 6/10 Entry $21.30 to $21.31 Now $9.32 −56.24% ▲ +0.05% −0.65% vs SPY
  5. Apr 22, 202629w ago DEFA14A Neutral 3/10 Entry $34.83 to $33.33 Now $9.32 −73.24% ▼ −4.31% −5.09% vs SPY
  6. Apr 19, 202630w ago Press Release Bullish 7/10 Entry $34.58 to $34.35 Now $9.32 −73.05% ▼ −0.67% −0.01% vs SPY
  7. Mar 23, 202634w ago S-3 Bearish 6/10 Entry $23.57 to $23.50 Now $9.32 +60.46% ▲ +0.30% +0.86% vs SPY
  8. Mar 23, 202634w ago Press Release Bullish 7/10 Entry $23.57 to $23.50 Now $9.32 −60.46% ▼ −0.30% −0.86% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026